{
    "2021-06-21": [
        [
            {
                "time": "",
                "original_text": "财经药点丨药企的“减法”：“三孩政策”后，回头看人福医药再卖杰士邦",
                "features": {
                    "keywords": [
                        "药企",
                        "减法",
                        "三孩政策",
                        "人福医药",
                        "杰士邦"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "当代集团艾路明：唯有不断创才能突破行业“天花板”",
                "features": {
                    "keywords": [
                        "当代集团",
                        "艾路明",
                        "创新",
                        "行业天花板"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合企业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}